128 related articles for article (PubMed ID: 2129251)
1. [Advances in fibrinolysis mediated by vascular endothelial cells].
Zhou QS
Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251
[No Abstract] [Full Text] [Related]
2. The role of vascular endothelial cells in the regulation of fibrinolysis.
Grulich-Henn J; Müller-Berghaus G
Z Kardiol; 1989; 78 Suppl 6():25-9. PubMed ID: 2694664
[TBL] [Abstract][Full Text] [Related]
3. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
Gurewich V
Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
[No Abstract] [Full Text] [Related]
4. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
5. [Plasminogen activators in tumor tissue].
Tomasiuk R; Mirowski M; Wierzbicki R
Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
[No Abstract] [Full Text] [Related]
6. Physiological consequences of loss of plasminogen activator gene function in mice.
Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
[TBL] [Abstract][Full Text] [Related]
8. The role of the pericellular fibrinolytic system in angiogenesis.
Fukao H; Ueshima S; Okada K; Matsuo O
Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
[No Abstract] [Full Text] [Related]
9. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
Sabovic M; Lijnen HR; Keber D; Collen D
Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasminogen activators.
Robbins KC; Barlow GH; Nguyen G; Samama MM
Semin Thromb Hemost; 1987 Apr; 13(2):131-8. PubMed ID: 3114881
[No Abstract] [Full Text] [Related]
11. Endothelium in hemostasis and thrombosis.
Lijnen HR; Collen D
Prog Cardiovasc Dis; 1997; 39(4):343-50. PubMed ID: 9050819
[TBL] [Abstract][Full Text] [Related]
12. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
13. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
14. Human plasminogen activators. Genes and proteins structure.
Blasi F; Riccio A; Sebastio G
Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
[No Abstract] [Full Text] [Related]
15. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.
van Hinsbergh VW; Koolwijk P; Hanemaaijer R
EXS; 1997; 79():391-411. PubMed ID: 9002228
[TBL] [Abstract][Full Text] [Related]
16. [Position and developmental trends in fibrinolytic therapy].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
[TBL] [Abstract][Full Text] [Related]
17. At the interface of fibrinolysis and inflammation: the role of urokinase-type plasminogen activator in the leukocyte extravasation cascade.
Reichel CA; Kanse SM; Krombach F
Trends Cardiovasc Med; 2012 Oct; 22(7):192-6. PubMed ID: 23062972
[TBL] [Abstract][Full Text] [Related]
18. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
19. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.
van Hinsbergh VW
Haemostasis; 1988; 18(4-6):307-27. PubMed ID: 3148525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
